Abstract
Multiple acute pulmonary complications occur in patients with hematologic malignancies. They might be associated with the disease itself, with complications from treatment, or with the consequences of an impaired immune status. Pulmonary leukostasis is one of the most common life-threatening complications in patients with hyperleukocytosis. The risk of this condition is higher in myeloid leukemia with white blood cell counts greater than 100,000 /µL. Leukostasis is a diagnostic challenge for clinicians due to non-specific symptoms and radiographic presentation. Definitive treatment of pulmonary leukostasis is still controversial; however, early detection and treatment by cytoreduction may improve outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Southwest Respiratory and Critical Care Chronicles
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
